India holds an important position in global pharmaceutical sector. It was valued to the worth of US$ 33 billion in 2017 and is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s domestic pharmaceutical market was reported to be of Rs 129,015 crore (US$ 18.12 billion) in 2018 with yearly growth rate of 9.4 %. Indian pharma market mainly composes of bulk drugs, intermediates, drug
formulations,biologicals, Ayurveda , Siddha and Unani (ASU) drugs and surgicals.
Safety, Traditional Medicine, Ayurveda